Neurol. praxi. 2010;11(1):13-15

Palliative care in patients with Parkinson's disease

prof.MUDr.Martin Bareš, Ph.D.
Centrum pro abnormní pohyby a parkinsonizmus Brno
I. neurologická klinika LF MU a FN u sv. Anny Brno

Parkinson‘s disease is a chronic, progressive neurological disease with prevalence of 1 % in the population over 65 years. The modern

success of pharmacology and deep-brain % of the populatstimulation surgery to treat the motor symptoms of tremor, rigidity, and

bradykinesia provide PD patients with longer lives and increased motor functioning. However, in the moderate and advanced stages of

disease, the therapeutic benefits of pharmacology diminish and motor symptoms are more complicated to treat. The nonmotor symptoms

of Parkinson´s disease receive little attention in clinical settings, although they can lead to disability and caregiver burden. The

concept of paliative care accepts the actual clinical disability of the patient and his needs for everyday life.

Keywords: Parkinson´s disease, paliative treatment, concept of care

Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bareš M. Palliative care in patients with Parkinson's disease. Neurol. praxi. 2010;11(1):13-15.
Download citation

References

  1. American Academy of Neurology Ethics and Humanities Subcommittee. Palliative care in neurology. Neurology 1996; 46: 870-872. Go to PubMed...
  2. Bareš M. Parkinsonova nemoc - diagnostika, klinické příznaky. Neurol. pro praxi 2001; 2(1): 22-25.
  3. Bareš M. Senzitivní příznaky Parkinsonovy nemoci. Cesk Slov Neurol 2001; 64/97(3): 139-143.
  4. Bareš M. Pozdní hybné komplikace Parkinsonovy nemoci - wearing-off a další motorické fluktuace. Neurol. pro praxi 2008; 9(2): 96-99.
  5. Egan K, Labyak M. Hospice care: A model for quality end of life. In: Ferrell BF and Coyle N. (Eds.): Textbook of palliative nursing. New York: Oxford, 2001: 7-26.
  6. Foley KM, Carver AC. Palliative care in neurology. Neurologic Clinics 2001; 19: 789-799. Go to original source... Go to PubMed...
  7. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23(6): 837-844. Go to original source... Go to PubMed...
  8. Hoehn MM, Yahr MD. Parkinsonism: Onset, progression, and mortality. Neurology 1967; 17: 427-441. Go to original source... Go to PubMed...
  9. MacMahon DG, Thomas S. Practical approach to quality of life in Parkinson´s disease: The nurse´s role. J Neurol 1998; 245(Suppl. 1): S19-S22. Go to original source... Go to PubMed...
  10. Marsden CD. Problems with long lerm-levodopa therapy for Parkinson´s disease. Clin Neuropharmacol 1994; 17: 32-44. Go to PubMed...
  11. Rektorová I. Psychiatrické symptomy Parkinsonovy nemoci: diagnostika a léčba. Neurol. pro praxi 2007; 8(5): 291-294.
  12. Richards M, Marder K, Cote L, Mayeux R. Reliability of symptom onset assessment in Parkinson´s disease. Mov Disord 1994; 9: 340-342. Go to original source... Go to PubMed...
  13. Roth J, Havránková P. Vztah motorických a non-motorických symptomů Parkinsonovy nemoci k dopaminergní terapii: část druhá. Neurol. pro praxi 2008; 9(2): 100-103.
  14. Sage JI. Pain in Parkinson´s disease. Curr Treat Option Neurol 2004; 6: 191-200. Go to original source... Go to PubMed...
  15. Sláma O. Několik poznámek o paliativní péči u amyotrofické laterální sklerózy. Neurol. pro praxi 2006; 1: 15.
  16. Tetrud J. Treatment challenges in early stage Parkinson's disease. Neurol Clin 2004; (3 Suppl): S19-33. Go to original source... Go to PubMed...
  17. Thomas S, MacMahon D. Parkinson´s disease, palliative care, and older people: Part 1. Nursing Older People 2004a; 16(1): 22-26. Go to original source... Go to PubMed...
  18. Thomas S, MacMahon D. Parkinson´s disease, palliative care, and older people: Part 2. Nursing Older People 2004b; 16(2): 22-26. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.